PREDICT STUDY FINAL RESULTS: EFFICACY AND SAFETY OF 24-WK REGIMEN OF PEGINTERFERON ALFA-2B PLUS WEIGHT-BASED RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE 1 (G1) WITH LOW VIRAL LOAD WHO ACHIEVE RAPID VIRAL RESPONSE
Авторы
Craxi A. 1 , Zuckerman E. 2 , Koutsounas S. 3 , Ogurtsov P.P.4 , Chemello L. 5 , Maticic M.B. 6 , Torras X. 7 , Diago M. 8 , Tartaglione M. 9 , Witthoeft T. 10 , Yu X. 11 , Chaudhri E.I. 11 , Pedicone L. 11 , Faruqi R. 11